[Ip-health] EGA Report: Patent-related barriers to market entry for generic medicines in the EU

[Judit Rius Sanjuan]

PATENT-RELATED BARRIERS TO MARKET ENTRY FOR GENERIC MEDICINES IN THE
EUROPEAN UNION:  A review of weaknesses in the current European patent
system and their impact on the market access of generic medicines

Patents play an important role in modern society, encouraging the
creation, dissemination and efficient exploitation of new technology.

Generic medicines play an equally important role in promoting
pharmaceutical innovation, affordability and sustainability. Immediate
market access of generic medicines after patent expiry is crucial to
society.

When patents=97of sometimes questionable quality=97are misused merely to
prevent others from innovating and competing, they can present a
formidable barrier to entry onto the generic medicines market.

This report identifies some of the patent-related hurdles facing
generic medicines in the European Union.

See the full report and press release at : http://www.egagenerics.com/


Judit Rius Sanjuan
Attorney
Knowledge Ecology International / Essential Information
www.keionline.org / www.cptech.org
Phone: +1.202.332.2670, x18